Mode of Action of RNA/DNA Oligonucleotides
- 1 March 2002
- Vol. 121 (3) , 91S-97S
- https://doi.org/10.1378/chest.121.3_suppl.91s
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Longitudinal Follow-up of Patients With α1-Protease Inhibitor Deficiency Before and During Therapy With IV α1-Protease InhibitorChest, 2001
- Correction of the UDP-glucuronosyltransferase gene defect in the Gunn rat model of Crigler–Najjar syndrome type I with a chimeric oligonucleotideProceedings of the National Academy of Sciences, 1999
- Gene Repair Using Chimeric RNA/DNA OligonucleotidesSeminars in Liver Disease, 1999
- Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectorsProceedings of the National Academy of Sciences, 1998
- In vivo site-directed mutagenesis of the factor IX gene by chimeric RNA/DNA oligonucleotidesNature Medicine, 1998
- Therapeutic gene targetingGene Therapy, 1998
- Targeted nucleotide exchange in the alkaline phosphatase gene of HuH-7 cells mediated by a chimeric RNA/DNA oligonucleotideHepatology, 1997
- Correction of the Mutation Responsible for Sickle Cell Anemia by an RNA-DNA OligonucleotideScience, 1996
- Targeted gene correction of episomal DNA in mammalian cells mediated by a chimeric RNA.DNA oligonucleotide.Proceedings of the National Academy of Sciences, 1996
- alpha 1-Antitrypsin: molecular pathology, leukocytes, and tissue damage.Journal of Clinical Investigation, 1986